NCT01444573

Rate Ventricular Control Therapy in Patients With Permanent Atrial Fibrillation

Rate Ventricular Control Therapy by Implantable Continuous Monitor in Patients With Permanent Atrial Fibrillation

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 90 (estimated)
• Sponsor: Meshalkin Research Institute of Pathology of Circulation · Network
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The investigators hypothesized that very lenient rate control is not inferior to strict or lenient rate control assessed by implantable continuous ECG monitor for preventing cardiovascular hospitalization and mortality in patients with long-standing persistent or permanent atrial fibrillation

Conditions

• Atrial Fibrillation

Interventions

Type	Name	Description
DEVICE	implantable continuous monitor	The Reveal XT was implanted in the parasternal area of the chest. The requirement for defining the exact final position was an R-wave amplitude ≥0.4 mV assessed through the Vector Check.

Timeline

• Start date: 2011-09-01
• Primary completion: 2012-12-01
• Completion: 2015-09-01
• First posted: 2011-09-30
• Last updated: 2015-09-23

Locations

1 site across 1 country: Russia